These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


311 related items for PubMed ID: 9341115

  • 1. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G, Yu-Lee L.
    J Biol Chem; 1997 Oct 24; 272(43):26841-9. PubMed ID: 9341115
    [Abstract] [Full Text] [Related]

  • 2. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.
    Mol Endocrinol; 1998 Apr 24; 12(4):556-67. PubMed ID: 9544991
    [Abstract] [Full Text] [Related]

  • 3. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
    Moriggl R, Gouilleux-Gruart V, Jähne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F.
    Mol Cell Biol; 1996 Oct 24; 16(10):5691-700. PubMed ID: 8816482
    [Abstract] [Full Text] [Related]

  • 4. Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter.
    Wang Y, O'Neal KD, Yu-Lee L.
    Mol Endocrinol; 1997 Aug 24; 11(9):1353-64. PubMed ID: 9259325
    [Abstract] [Full Text] [Related]

  • 5. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
    Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8831-5. PubMed ID: 7568026
    [Abstract] [Full Text] [Related]

  • 6. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G.
    Mol Endocrinol; 2001 Nov 12; 15(11):1941-52. PubMed ID: 11682625
    [Abstract] [Full Text] [Related]

  • 7. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F, Chiarenza A, Goffin V, Kelly PA.
    Mol Endocrinol; 1996 Apr 12; 10(4):451-60. PubMed ID: 8721989
    [Abstract] [Full Text] [Related]

  • 8. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
    Park SH, Yamashita H, Rui H, Waxman DJ.
    Mol Endocrinol; 2001 Dec 12; 15(12):2157-71. PubMed ID: 11731617
    [Abstract] [Full Text] [Related]

  • 9. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5.
    Fleenor DE, Freemark M.
    Endocrinology; 2001 Jul 12; 142(7):2805-10. PubMed ID: 11415999
    [Abstract] [Full Text] [Related]

  • 10. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N, Matsuda T.
    J Biol Chem; 2000 Dec 15; 275(50):39718-26. PubMed ID: 10993888
    [Abstract] [Full Text] [Related]

  • 11. Selective coupling of STAT factors to the mouse prolactin receptor.
    Mayr S, Welte T, Windegger M, Lechner J, May P, Heinrich PC, Horn F, Doppler W.
    Eur J Biochem; 1998 Dec 01; 258(2):784-93. PubMed ID: 9874248
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.
    Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM.
    J Biol Chem; 1999 Aug 06; 274(32):22484-92. PubMed ID: 10428824
    [Abstract] [Full Text] [Related]

  • 13. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
    Carsol JL, Gingras S, Simard J.
    Mol Endocrinol; 2002 Jul 06; 16(7):1696-710. PubMed ID: 12089361
    [Abstract] [Full Text] [Related]

  • 14. Association of 2',5'-oligoadenylate synthetase with the prolactin (PRL) receptor: alteration in PRL-inducible stat1 (signal transducer and activator of transcription 1) signaling to the IRF-1 (interferon-regulatory factor 1) promoter.
    McAveney KM, Book ML, Ling P, Chebath J, Yu-Lee L.
    Mol Endocrinol; 2000 Feb 06; 14(2):295-306. PubMed ID: 10674401
    [Abstract] [Full Text] [Related]

  • 15. Multiple stat complexes interact at the interferon regulatory factor-1 interferon-gamma activation sequence in prolactin-stimulated Nb2 T cells.
    Wang YF, Yu-Lee LY.
    Mol Cell Endocrinol; 1996 Jul 23; 121(1):19-28. PubMed ID: 8865162
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biphasic transcriptional regulation of the interferon regulatory factor-1 gene by prolactin: involvement of gamma-interferon-activated sequence and Stat-related proteins.
    Stevens AM, Wang YF, Sieger KA, Lu HF, Yu-Lee LY.
    Mol Endocrinol; 1995 Apr 23; 9(4):513-25. PubMed ID: 7659094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
    Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S, Chretien S.
    Mol Cell Biol; 1998 Oct 23; 18(10):5852-60. PubMed ID: 9742102
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.